Advocacy

ENDO 08 Highlights from the Government and Public Affairs Department

Endocrine Insider
June 27, 2008

Media
ENDO 08 generated excellent international coverage of The Endocrine Society and its members' research. More than 75 reporters (both on-site and on-line) participated in seven news conferences highlighting some of the most compelling and newsworthy findings presented at the Society's annual meeting. Members of the Society's Advocacy and Public Outreach Core Committee served as moderators for the news conferences. Coverage appeared in USA Today, the LA Times, Reuters, the Sacramento Bee, Science News, WebMD, the Washington Post, and more than 400 other print, broadcast, and on-line media outlets. Data from nearly 30 separate oral and poster presentations were reported.

The Society also unveiled to the media its new position statement on steroid abuse, which calls for enhanced detection of steroid abuse among professional and amateur athletes and for greater education to deter teenagers and others from putting their health in jeopardy through steroid doping. The new statement also supports the appropriate clinical use of anabolic steroids.

To view the full statement, please click on the following link: statement on steroid abuse.

Media coverage of note includes:

 Advocacy
In order to increase awareness of issues important to the Society's membership, Government & Public Affairs staff provided ENDO attendees with an opportunity to participate in grassroots advocacy by writing to their senators and representatives about three critical issues: increasing funding for NIH in FY2009, halting the impending physician payment cuts, and reversing the dual energy x-ray absorptiometry (DXA) payment cuts. Strong interest among attendees in these issues resulted in hundreds of letters sent to members of Congress in support of the Society's advocacy agenda. 

 Clinical Practice Guidelines
ENDO 08 featured scientific sessions on four recently completed Endocrine Society clinical practice guidelines— Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk; Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism; Evaluation and Treatment of Hirsutism in Premenopausal Women; and Diagnosis of Cushing's Syndrome. Each session included an overview of the guideline from the chair of the task force that developed it, including recommendations and challenges, and an open discussion led by an independent moderator. 

During its June 13 meeting, Council unanimously approved the Society clinical practice guideline Evaluation and Management of Adult Hypoglycemic Disorders.  That guideline will now be submitted to JCEM.